Skip to content

Clinical trials

Observational Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Phase: Observational Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20121
20141
20171
20181
20201
20211
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Not yet recruiting2
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group4
St. Jude Children's Research Hospital3
National Cancer Institute (NCI)2
Centre Oscar Lambret1
Florida International University1
Labcorp Corporation of America Holdings, Inc1
Lille University1
Power Life Sciences Inc.1
Sohag University1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma18
Sarcoma11
Osteosarcoma6
Sarcoma, Ewing6
Neuroblastoma4
Neoplasms3
Retinoblastoma3
Leukemia2
Lymphoma2
Melanoma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.